| [1] |
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society[J]. J Am Coll Cardiol, 2018, 72(14):e91-e220.
|
| [2] |
Liu Q, Wang Y, Ehdaie A, et al. False tendons in the left ventricle: implications for successful ablation of left posterior fascicular tachycardias[J]. JACC Clin Electrophysiol, 2023, 9(9):1914-1929.
|
| [3] |
Liang M, Wang Z, Li Y, et al. Purkinje fibers in canine false tendons: new anatomical and electrophysiological findings[J]. Cardiol Res Pract, 2020, 2020:8156928.
|
| [4] |
Nikolaou M, Parissis J, Yilmaz MB, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure[J]. Eur Heart J, 2013, 34(10):742-749.
|
| [5] |
Abozaid W, Wong S, Deyell MW, et al. Tachycardia-induced cardiomyopathy: a case series and a literature review[J]. CJC Pediatr Congenit Heart Dis, 2024, 3(6):272-284.
|
| [6] |
Arslan A, Erdoğan İ, Varan B, et al. Reversible cardiomyopathy-tachycardiomyopathy in children[J]. Turk J Pediatr, 2019, 61(4):552-559.
|
| [7] |
Spinale FG, Tanaka R, Crawford FA, et al. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy[J]. Circulation, 1992, 85(2):717-729.
|
| [8] |
Martin CA, Lambiase PD. Pathophysiology, diagnosis and treatment of tachycardiomyopathy[J]. Heart, 2017, 103(19):1543-1552.
|
| [9] |
Ulus T, Okyay K, Kabul HK, et al. Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy[J]. Anatol J Cardiol, 2019, 21(2):98-106.
|
| [10] |
Gong H, Wang X, Ling Y, et al. Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function[J]. Exp Ther Med, 2014, 7(6):1506-1512.
|
| [11] |
徐欣怡, 顾怡菁, 郭颖, 等. 儿童心动过速性心肌病的临床管理及预后分析[J]. 中华心脏与心律电子杂志, 2023, 11(4):216-221.
|
| [12] |
Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs. non-coronary disease[J]. Eur Heart J, 2011, 32(4):404-411.
|
| [13] |
Oomen A, Dekker L, Meijer A. Catheter ablation of symptomatic idiopathic ventricular arrhythmias : a five-year single-centre experience[J]. Neth Heart J, 2018, 26(4):210-216.
|
| [14] |
Liu Q, Shehata M, Jiang R, et al. Macroreentrant loop in ventricular tachycardia from the left posterior fascicle: new implications for mapping and ablation[J]. Circ Arrhythm Electrophysiol, 2016, 9(9):e004272.
|
| [15] |
Talib AK, Nogami A, Nishiuchi S, et al. Verapamil-sensitive upper septal idiopathic left ventricular tachycardia: prevalence, mechanism, and electrophysiological characteristics[J]. JACC Clin Electrophysiol, 2015, 1(5):369-380.
|
| [16] |
Nair GM, Thomas V, Stoyanov N, et al. Upper septal transformation of verapamil-sensitive idiopathic left ventricular tachycardia during catheter ablation: Wolf in sheep׳s clothing?[J]. HeartRhythm Case Rep, 2016, 2(1):101-106.
|
| [17] |
Yamaguchi J, Nagata Y, Yamauchi Y, et al. New implications for the recurrence mechanism of an upper septal ventricular tachycardia: a case report[J]. Eur Heart J Case Rep, 2019, 3(2):ytz079.
|
| [18] |
Nogami A. What is the real identity of the mysterious potential P1, and what is the most important segment of the fascicular ventricular tachycardia circuit?[J]. Circ Arrhythm Electrophysiol, 2016, 9(9):e004517.
|